Back to mobile site

Hi-Tech Pharmacal Co. (HITK) Tops Q2 EPS by 7c

December 6, 2012 7:09 AM EST Send to a Friend
Hi-Tech Pharmacal Co. (NASDAQ: HITK) reported Q2 EPS of $0.66 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login